Quarterly Results

  • Company Name :
Biocon Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 532523
  • NSE Symbol:
  • BIOCON
  • P/E(TTM):
  • -
  • ISIN Demat:
  • INE376G01013
  • Div & Yield%:
  • 0.38
  • EPS(TTM):
  • 0.41
  • Book Value(₹):
  • 95.98
  • Market Cap(₹Cr.):
  • 39,619.80
  • Face Value(₹):
  • 5.00
Quarters :  
Particulars March 2025 ( Cr)December 2024 ( Cr)September 2024 ( Cr)
Gross Sales 643.80 562.80 525.40
Excise Duty 0.00 0.00 0.00
Net Sales 643.80 562.80 525.40
Other Operating Income 0.00 0.00 0.00
Other Income 62.70 671.70 73.50
Total Income 706.50 1,234.50 598.90
Total Expenditure 581.80 531.50 487.80
PBIDT 124.70 703.00 111.10
Interest 56.70 65.30 59.70
PBDT 68.00 637.70 51.40
Depreciation 33.00 33.80 30.50
Tax 26.50 8.40 13.20
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -12.70 11.50 4.50
Reported Profit After Tax 21.20 584.00 3.20
Extra-ordinary Items 0.00 587.60 0.00
Adjusted Profit After Extra-ordinary item 21.20 -3.60 3.20
EPS (Unit Curr.) 0.18 4.88 0.03
EPS (Adj) (Unit Curr.) 0.18 4.88 0.03
Calculated EPS (Unit Curr.) 0.18 4.86 0.03
Calculated EPS (Adj) (Unit Curr.) 0.18 4.86 0.03
Calculated EPS (Ann.) (Unit Curr.) 0.71 19.46 0.11
Calculated EPS (Adj) (Ann.) (Unit Curr.) 0.71 19.46 0.11
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 600.30 600.30 600.30
Reserve & Surplus 0.00 0.00 0.00
Face Value 5.00 5.00 5.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 19.37 124.91 21.15
PBDTM(%) 10.56 113.31 9.78
PATM(%) 3.29 103.77 0.61